Andrew Lee, MD
Radiation Oncology · Irving, TXNPI 1487746129
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (33.2%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Tolmar Pharmaceuticals, Inc. at 37.0% of the total. Reporting peaked in 2022 at $6,224 and has fallen 95.8% since, to $264 in 2025. Among radiation oncology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 49 payments — averaging $341.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tolmar Pharmaceuticals, Inc.$6K
- Ion Beam Applications S.A.$3K
- Sanofi$2K
- Tolmar, Inc.$2K
- IBA Proton Therapy, Inc.$1K
- Blue Earth Diagnostics$569
- plus $992 from 8 others
What the payments were for
- Consulting fees$5,54933%
- Speaking & faculty fees$4,40026%
- Travel & lodging$1,5009%
- Food & beverage$5,26532%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tolmar Pharmaceuticals, Inc. | 12 | $6,178 |
| Ion Beam Applications S.A. | 2 | $3,424 |
| Sanofi | 1 | $2,319 |
| Tolmar, Inc. | 3 | $1,875 |
| IBA Proton Therapy, Inc. | 4 | $1,357 |
| Blue Earth Diagnostics | 12 | $569 |
| Progenics Pharmaceuticals, Inc. | 8 | $440 |
| Palette Life Sciences, Inc. | 1 | $168 |
| Siemens Medical Solutions USA, Inc. | 1 | $129 |
| Viewray Technologies Inc | 1 | $87 |
| TG Therapeutics, Inc. | 1 | $62 |
| Bioprotect Medical, Inc. | 1 | $48 |
| Icotec Medical Inc. | 1 | $39 |
| Telix Pharmaceuticals | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIGARD$5,830
- JEVTANA$2,319
- POSLUMA$391
- PYLARIFY$237
- SOMATOM go.Top$129
- Biograph Vision 600 (8 Ring/64 CT)$129
How this compares
$16,714 in reported general payments places this provider in the 90th percentile of 418 radiation oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 310 | $4,324 |
| Bicalutamide | 56 | $1,192 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 17 | $400 |
| Levofloxacin | 62 | $199 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Irving
- James WelshHouston$421K
- Stephen ChunHouston$344K
- Jim HsiangCorpus Christi$258K
- Chad TangHouston$183K
- Phuoc TranHouston$177K
- Hak ChoyDallas$119K
- Steven LinHouston$105K
- Benjamin SchrankHouston$100K
- Robert TimmermanDallas$77K
- Abhilasha PatelHouston$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.